What to Expect from Quest Diagnostics (DGX) as Q2 2024 Earnings Release Nears
Friday, 12 July 2024, 13:02
Quest Diagnostics (DGX) Q2 2024 Earnings Overview
Quest Diagnostics (DGX) is expected to maintain a robust base business performance in the second quarter of 2024.
COVID-19 Testing Revenues
Impact: Declining COVID-19 testing revenues could restrict overall growth for Quest Diagnostics (DGX).
Investors are closely monitoring this aspect to gauge the financial health of the company.
- Strong base business performance
- Challenges from COVID-19 testing revenues
The upcoming earnings release will provide valuable insights into the company's current financial status.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.